China Neurodegenerative Disorder Therapeutics Market (2025-2031) | Segmentation, Outlook, Analysis, Size & Revenue, Industry, Competitive Landscape, Share, Forecast, Companies, Trends, Value, Growth

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 China Country Macro Economic Indicators

3.2 China Neurodegenerative Disorder Therapeutics Market Revenues & Volume, 2021 & 2031F

3.3 China Neurodegenerative Disorder Therapeutics Market - Industry Life Cycle

3.4 China Neurodegenerative Disorder Therapeutics Market - Porter's Five Forces

3.5 China Neurodegenerative Disorder Therapeutics Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.6 China Neurodegenerative Disorder Therapeutics Market Revenues & Volume Share, By Drug Glass, 2021 & 2031F

3.7 China Neurodegenerative Disorder Therapeutics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 China Neurodegenerative Disorder Therapeutics Market Revenues & Volume Share, By End- User, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of neurodegenerative disorders in China

4.2.2 Rising geriatric population in China

4.2.3 Technological advancements in neurodegenerative disorder therapeutics

4.2.4 Growing healthcare expenditure in China

4.2.5 Government initiatives to improve healthcare infrastructure and access to treatment

4.3 Market Restraints

4.3.1 High cost of neurodegenerative disorder therapeutics

4.3.2 Stringent regulatory requirements for drug approval

4.3.3 Limited awareness about neurodegenerative disorders and available treatment options in China

4.3.4 Challenges in research and development of innovative therapies

4.3.5 Competition from alternative treatment options and therapies

6.1 China Neurodegenerative Disorder Therapeutics Market, By Indication

6.1.1 Overview and Analysis

6.1.2 China Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Indication, 2021- 2031F

6.1.3 China Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Multiple sclerosis, 2021- 2031F

6.1.4 China Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Alzheimers Disease, 2021- 2031F

6.1.5 China Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Parkinsons Disease, 2021- 2031F

6.1.6 China Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Huntingtons Disease, 2021- 2031F

6.1.7 China Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Others, 2021- 2031F

6.2 China Neurodegenerative Disorder Therapeutics Market, By Drug Glass

6.2.1 Overview and Analysis

6.2.2 China Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Immunomodulator, 2021- 2031F

6.2.3 China Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Interferons, 2021- 2031F

6.2.4 China Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Decarboxylase Inhibitors, 2021- 2031F

6.2.5 China Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Dopamine Agonists, 2021- 2031F

6.2.6 China Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Others, 2021- 2031F

6.3 China Neurodegenerative Disorder Therapeutics Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 China Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Oral, 2021- 2031F

6.3.3 China Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Injection, 2021- 2031F

6.3.4 China Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Transdermal, 2021- 2031F

6.4 China Neurodegenerative Disorder Therapeutics Market, By End- User

6.4.1 Overview and Analysis

6.4.2 China Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.4.3 China Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.4.4 China Neurodegenerative Disorder Therapeutics Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

7.1 China Neurodegenerative Disorder Therapeutics Market Export to Major Countries

7.2 China Neurodegenerative Disorder Therapeutics Market Imports from Major Countries

8.1 Number of clinical trials for neurodegenerative disorder therapeutics in China

8.2 Adoption rate of novel therapies in the market

8.3 Patient outcomes and quality of life improvements with new treatments

8.4 Investment in research and development for neurodegenerative disorder therapeutics

8.5 Number of healthcare facilities offering specialized care for neurodegenerative disorders

9.1 China Neurodegenerative Disorder Therapeutics Market Opportunity Assessment, By Indication, 2021 & 2031F

9.2 China Neurodegenerative Disorder Therapeutics Market Opportunity Assessment, By Drug Glass, 2021 & 2031F

9.3 China Neurodegenerative Disorder Therapeutics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 China Neurodegenerative Disorder Therapeutics Market Opportunity Assessment, By End- User, 2021 & 2031F

10.1 China Neurodegenerative Disorder Therapeutics Market Revenue Share, By Companies, 2024

10.2 China Neurodegenerative Disorder Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters